Literature DB >> 3011667

Characteristics of aggregated immunoglobulin G as an immunologic phagocytic stimulus for granule enzyme release from human neutrophils.

R J Smith, S C Speziale, R G Ulrich, B J Bowman.   

Abstract

Aggregated immunoglobulin G (AggIgG) induced a time- and concentration-dependent phagocytic release of granule-associated lysozyme and myeloperoxidase (MPO) from human neutrophils. Degranulation was significantly enhanced in the presence of calcium or magnesium, and maximum granule exocytosis was observed when both divalent cations were present. AggIgG-stimulated enzyme release was inhibited with the intracellular calcium antagonist, TMB-8[8-(N,N-diethylamino)-octyl-(3,4,5-trimethoxy)benzoate] in the absence of extracellular calcium. DIDS (4,4'-diisothiocyano-2,2'-disulfonic acid stilbene), a permeant anion channel blocker, also suppressed AggIgG-induced degranulation. Cycloheximide, an inhibitor of protein synthesis, enhanced granule exocytosis from AggIgG-treated neutrophils. Two inhibitors of transmethylation reactions, 3-deazaadenosine (3-DZA) and homocysteine thiolactone (HCTL) in combination, suppressed AggIgG-elicited granule enzyme release. These data indicate that AggIgG is a useful probe for investigating the requirements for phagocytic enzyme release from human neutrophils.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3011667     DOI: 10.1007/bf00915995

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  25 in total

1.  Intracellular control of human neutrophil secretion. I. C5a-induced stimulus-specific desensitization and the effects of cytochalasin B.

Authors:  P M Henson; B Zanolari; N A Schwartzman; S R Hong
Journal:  J Immunol       Date:  1978-09       Impact factor: 5.422

2.  Modulation of human neutrophil superoxide anion generation by the calcium antagonist 8-(N,N-diethylamino)-octyl-(3,4,5-trimethoxy) benzoate hydrochloride.

Authors:  R J Smith; S S Iden
Journal:  J Reticuloendothel Soc       Date:  1981-03

3.  Stimulus-response coupling in the human neutrophil. Transmembrane potential and the role of extracellular Na+.

Authors:  H M Korchak; G Weissmann
Journal:  Biochim Biophys Acta       Date:  1980-09-02

4.  Stimulus response coupling in the human neutrophil. I. Kinetic analysis of changes in calcium permeability.

Authors:  H M Korchak; L E Rutherford; G Weissmann
Journal:  J Biol Chem       Date:  1984-04-10       Impact factor: 5.157

5.  Chemoattractants stimulate degradation of methylated phospholipids and release of arachidonic acid in rabbit leukocytes.

Authors:  F Hirata; B A Corcoran; K Venkatasubramanian; E Schiffmann; J Axelrod
Journal:  Proc Natl Acad Sci U S A       Date:  1979-06       Impact factor: 11.205

6.  Effects of an anion channel blocker, 4, 4'-diisothiocyano-2,2'-disulfonic acid stilbene (DIDS), on human neutrophil function.

Authors:  R J Smith; B J Bowman; S S Iden
Journal:  Biochem Biophys Res Commun       Date:  1984-05-16       Impact factor: 3.575

7.  Inhibition of IgE-mediated histamine release from rat basophilic leukemia cells and rat mast cells by inhibitors of transmethylation.

Authors:  Y Morita; R P Siraganian
Journal:  J Immunol       Date:  1981-10       Impact factor: 5.422

8.  Activation of the human neutrophil secretory process with 5(S),12(R)-dihydroxy-6,14-cis-8,10-trans-eicosatetraenoic acid.

Authors:  R J Smith; S S Iden; B J Bowman
Journal:  Inflammation       Date:  1984-12       Impact factor: 4.092

9.  Transmethylation reactions are required for initial morphologic and biochemical responses of human monocytes to chemoattractants.

Authors:  M C Pike; R Snyderman
Journal:  J Immunol       Date:  1981-10       Impact factor: 5.422

10.  Anion channel blockers inhibit lysosomal enzyme secretion from human neutrophils without affecting generation of superoxide anion.

Authors:  H M Korchak; B A Eisenstat; S T Hoffstein; P B Dunham; G Weissmann
Journal:  Proc Natl Acad Sci U S A       Date:  1980-05       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.